BASL logo

News

Belgium hepatitis free in 2030

The result of the vision document ‘Belgium 2030 hepatitis-free’

In order to reach the WHO target of eliminating HCV as a public health threat by 2030, a group of Belgian HCV experts, some of which are active BASL steering committee members, joined the Belgian HCV coalition, which is supported by an unrestricted grant from pharmaceutical companies and a communication bureau.

On 9 October 2020, the coalition organised a roundtable to discuss the Belgian hepatitis policy. This resulted in the vision document ‘Belgium 2030 hepatitis-free’, which can be consulted here in Dutch and French.

Next BASL Winter Meeting and Liver Course: November 27th and 28th.

BASL Winter Meeting and Liver Course 2025

Next BASL Winter Meeting and Liver Course: November 26th and 27th.

BASL Winter Meeting and Liver Course 2026

Genetics in adult hepatology. How can you introduce it in your clinical practice?

Ghent Liver Day 2025

BASL - Belgian Association for the Study of the Liver
Leuvensesteenweg 643
1930 Nossegem
basl(at)basl.be